Chronic treatment with clozapine selectively decreases basal dopamine release in nucleus accumbens but not in caudate-putamen as measured by in vivo brain microdialysis: Further evidence for depolarization block-Reference-Cited by-同舟云学术

Chronic treatment with clozapine selectively decreases basal dopamine release in nucleus accumbens but not in caudate-putamen as measured by in vivo brain microdialysis: Further evidence for depolarization block

Published:1991-01 Issue:1 Volume:122 Page:127-131
ISSN:0304-3940
Container-title:Neuroscience Letters
language:en
Short-container-title:Neuroscience Letters

Author:

Chen Jianping,Paredes William,Gardner Eliot L.

Publisher

Elsevier BV

Subject

General Neuroscience

Reference24 articles.

1. Typical and atypical antipsychotic occupancy of D-2 and S-2 receptors: an autoradiographic analysis in rat brain;Altar;Brain Res. Bull.,1986

2. Chemotherapy in Psychiatry: Principles and Practice;Baldessarini,1985

3. Direct in vivo electrochemical monitoring of dopamine release in response to neuroleptic drugs;Blaha;Eur. J. Pharmacol.,1984

4. Chronic treatment with classical and atypical antipsychotic drugs differentially decreases dopamine release in striatum and nucleus accumbens in vivo;Blaha;Neurosci. Lett.,1987

5. Neuroleptics increase striatal catecholamine metabolites but not ascorbic acid in dialyzed perfusate;Blakely;Brain Res.,1984

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dopamine and Addiction;Annual Review of Psychology;2020-01-04

2. Dopamine, the antipsychotic molecule: A perspective on mechanisms underlying antipsychotic response variability;Neuroscience & Biobehavioral Reviews;2018-02

3. Clozapine and GABA transmission in schizophrenia disease models;Pharmacology & Therapeutics;2015-06

4. Regional Differences in the Action of Antipsychotic Drugs: Implications for Cognitive Effects in Schizophrenic Patients;Staging Neuropsychiatric Disorders;2013

5. Regional Differences in the Action of Antipsychotic Drugs: Implications for Cognitive Effects in Schizophrenic Patients;Neurotoxicity Research;2010-04-08